From: PET/CT in restaging, prognosis, and recurrence in patients with malignant melanoma
Total stage grouping
Stage grouping
No. of patients
Percentage
IA
0
0%
IIA
2
4%
IIB
4
8%
IIC
5
10%
IIIA
7
14%
IIIB
IIIC
10
20%
IV
18
54%
Total
50
100%